Ocugen, Inc. cotiza a 0.95 USD y tiene una capitalización bursátil de $321M. En los últimos 12 meses ha facturado $5M con un margen de flujo de caja libre del -1295.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.06 | $-0.06 | $-0.06 |
| Estimado | $-0.05 | $-0.05 | $-0.05 | $-0.06 |
| Sorpresa | — | -20.0% | -20.0% | +0.0% |
| Métrica | OCGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -1425.7% | -38.6% | -1387.1% |
| Net Margin | -1537.4% | -33.6% | -1503.9% |
| FCF Margin | -1295.0% | -13.9% | -1281.2% |
| ROE | — | -40.4% | — |
| ROA | -155.9% | -32.0% | -123.9% |
| Current Ratio | 1.06 | 2.84 | -1.78 |
| Debt / Equity | -2.26 | 0.28 | -2.54 |